Literature DB >> 7354453

New calculation method of mean total body clearance of drugs and its application to dosage regimens.

W L Chiou.   

Abstract

A new method for calculating the mean total body drug clearance is proposed for determining the mean dosing rate for patients. In this method, the mean clearance can be calculated from the individual clearance values by the harmonic mean method, or it can be determined by dividing the same absorbed dose by the arithmetic mean of the areas under the plasma level-time curve from time zero to infinity from all of the subjects or patients studied. In this method, the arithmetic mean method is assumed to have been used for calculation of literature mean plasma levels. Various methods for calculating mean clearances also are evaluated. These methods yield different mean clearance values from the same set of individual data, resulting in different dosage regimen recommendations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354453     DOI: 10.1002/jps.2600690125

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.

Authors:  Soo K Bae; Won-Suk Chung; Eun J Kim; Jae K Rhee; Jong W Kwon; Won B Kim; Myung G Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.

Authors:  Jee H Shin; Ka Y Choi; Yu C Kim; Myung G Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.

Authors:  Y H Choi; M G Lee
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

4.  Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.

Authors:  S H Kim; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.

Authors:  S H Kim; H J Shim; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.

Authors:  S H Kim; J W Kwon; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

7.  Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.

Authors:  D P Crankshaw; N E Edwards; G L Blackman; M D Boyd; H N Chan; D J Morgan
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

Authors:  G Robbie; W L Chiou
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

9.  Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

10.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.